Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia: A Multicenter, Prospective Study

NCT06516679 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06516679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06516679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia: A Multicenter, Prospective Study
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Recruiting
Start date
December 11, 2024
Completion date
December 31, 2032
Enrollment
40 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoid